Atovaquone Impurity 3 | CAS 95233-36-6 - Request Quote
Atovaquone Impurity 3
| SZ CAT No: | SZ-A041008 |
| CAS No | 95233-36-6 |
| Mol.F. | C14H17ClO |
| Mol.Wt. | 236.7 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Atovaquone Impurity 3 is chemically 1-(4-(4-Chlorophenyl)cyclohexyl)ethan-1-one. Atovaquone Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Atovaquone Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atovaquone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 95233-36-6
Purchase 95233-36-6
Order 95233-36-6
Enquire 95233-36-6
price of 95233-36-6
95233-36-6 Supplier
95233-36-6 Manufacturer
95233-36-6 Exporter
buy high quality Atovaquone Impurity 3
Purchase Atovaquone Impurity 3
Atovaquone Impurity 3 suppliers
Atovaquone Impurity 3 manufacturers
Atovaquone Impurity 3 price
Order Atovaquone Impurity 3
Enquire Atovaquone Impurity 3
Atovaquone Impurity 3 cost
Atovaquone Impurity 3 Supplier
Atovaquone Impurity 3 Distributor
Atovaquone Impurity 3 for Method Validation
Atovaquone Reference Standard
Atovaquone Impurity 3 for ANDA Filing
Atovaquone Impurity 3 for Forced Degradation Studies
Atovaquone Impurity 3 Identification Standards
Atovaquone Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.